Emerging Applications of Digital Genomics in Next-Generation Sequencing Will Promulgate Growth of Digital Genome Market
A digital genome is a digital set of genetic materials that transpires in an organism. It is regarded as a convenient way to collect data regarding chronic diseases and is widely practiced by experts to achieve a closer look at genetic complications. A digital genome acts as a supporter that offers instant access to the trait sequences to resolve the custom queries. Digital genomes associated with genes and their functions will assist in detecting causes behind several chronic disorders.
The digital genome has revolutionized the invention and research center to offer insights into the complicated genetic systems, thereby it is likely to drive the growth of the global digital genome market in the forthcoming years. Digital genomes are widely utilized in extensive applications including research & development, forensics, livestock & agriculture, transplantation microbiology, reproductive & genetic, and others. The end-user of the digital genome includes biopharmaceutical companies, hospitals, diagnostic centers, forensic labs, academic & research institutes. The significant growth in the technological advancements and innovations in the field of the digital genome will further help in the accurate and early diagnosis of attention deficit hyperactivity disorder, cancer, and diabetes. The emerging applications of digital genomics in next-generation sequencing will also boost the growth of the market significantly.
The global digital genome market can be segmented into application, product, and region.
By application, the market can be segmented into livestock & agriculture, transplantation, reproductive & genetic microbiology, research & development, and others. The research & development segment holds the largest share in the global digital genome market due to the growing number of private and public investments.
By product, the market can be segmented into sequencing chips, DNA, RNA, and sequencing & analyzer instruments. The sequencing & analyzer instruments segment accounts for the largest share in the global digital genome market due to the growing technological advancements in software packages for the evaluation of genomic sequence data.
Europe accounts for the largest share in the global digital genome market due to the presence of prominent market leaders in the region. The presence of robust healthcare infrastructure in the region will further propel the growth of the regional market.
Some of the significant players in the global digital genome market are Perkin Elmer, Inc., GenMark Diagnostics, Inc., bioMerieux SA, BD, NanoString Technologies, Inc., GenomeMe, QIAGEN, Illumina, Inc., F. THERMO FISHER SCIENTIFIC INC., and Agilent Technologies Inc. To cite, Google in December 2017 launched DeepVariant, an artificial intelligence (AI) tool to build an accurate model of the genome using sequencing data.
Get Sample of this Research Report for more Insights – https://www.zionmarketresearch.com/sample/digital-genome-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us –
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651